Medroxyprogesterone Acetate 150 mg/mL

Medroxyprogesterone Acetate 150 mg/mL is an extended-release injectable suspension used for various hormonal and reproductive health purposes. This medication is designed for intramuscular administration and is manufactured by Amphastar Pharmaceuticals, Inc.

Medroxyprogesterone Acetate 150 mg/mL is commonly used for hormonal therapy and reproductive health management. It may be prescribed for conditions related to menstrual disorders, endometriosis, or as a contraceptive method. The medication works by altering hormone levels in the body to achieve the desired therapeutic effects.

Common effects of Medroxyprogesterone Acetate 150 mg/mL may include changes in menstrual cycles, breast tenderness, and mood swings. Some individuals may experience headaches, dizziness, or weight changes. These effects can vary depending on the individual and the specific condition being treated.

Medroxyprogesterone Acetate 150 mg/mL should be used with caution in individuals with a history of blood clots, liver disease, or breast cancer. It is important to discuss any pre-existing medical conditions with a healthcare provider before starting this medication. Regular monitoring may be required to ensure safety and effectiveness.

Medroxyprogesterone Acetate 150 mg/mL may interact with certain medications, including those that affect liver enzymes or other hormonal therapies. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions. Alcohol consumption should be moderated, as it may affect the metabolism of the medication.